The human cathelicidin hCAP-18

Danish Medical Bulletin

Volumn 52, Issue 1, 2005, Pages 1-10

  Sørensen, Ole L ^a,b  

^a Rigshospitalet   (Denmark)

^b NONE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CATHELICIDIN; CATIONIC ANTIMICROBIAL PROTEIN 18; POLYPEPTIDE; UNCLASSIFIED DRUG;

ANTIMICROBIAL ACTIVITY; CELL GRANULE; CELL ULTRASTRUCTURE; EPITHELIUM CELL; HUMAN; INNATE IMMUNITY; NEUTROPHIL; PROTEIN DEGRADATION; PROTEIN DETERMINATION; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROCESSING; PROTEIN SYNTHESIS; REVIEW; SEMINAL PLASMA;

ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; BONE MARROW CELLS; EPIDIDYMIS; HUMANS; KERATINOCYTES; MALE; NEUTROPHILS;

EID: 27244437074     PISSN: 16039629     EISSN: 16039629     Source Type: Journal    
DOI: None     Document Type: Review

References (94)

1. Sørensen O, Cowland JB, Askaa J, Borregaard N: An ELISA for hCAP-18, the cathelicidin present in human neutrophils and plasma. J Immunol Methods 1997;206:53-59.
2. Sørensen O, Bratt T, Johnsen AH, Madsen MT, Borregaard N: The human antibacterial cathelicidin, hCAP-18, is bound to lipoprotiens in plasma. J Biol Chem 1999;274:22445-22451.
3. Sørensen O, Arnljots K, Cowland JB, Bainton DF, Borregaard N: The Human Antibacterial Cathelicidin, hCAP-18, is Synthesized Myelocytes and Metamyelocytes and Localized to Specific Granules in Neutrophils. Blood 1997;90:2796-2803.
4. Sørensen O, Follin P, Johnsen AH, Calafat J, Tjabringa GS, Hiemstra PS, Borregaard N: The human cathelicidin, hCAP-18, is processed extracellularly to the antimicrobial peptide LL-37 by proteinase 3. Blood 2001;97:3951-3959.
5. Sørensen O, Gram, Johnsen AH, Andersson E, Bangsbøll S, Tjabringa GS, Hiemstra PS, Malm J, Egesten A, Borregaard N: Processing of seminal plasma hCAP-18 to ALL-38 by gastricsin - a novel mechanism of generating antimicrobial peptides in vagina. J Biol Chem 2003;278:28540-28546.
6. Sørensen O, Cowland JB, Theilgaard-Mönch K, Liu L, Ganz T, Borregaard N: Woundhealing and expression of antimicrobial peptides/polypeptides in human keratinocytes - a consequence of common growth factors. J Immunol 2003;170:5583-5589.
7. Babior BM. NADPH oxidase: an update. Blood 1999;93:1464-1476.
8. Nauseef WM. The NADPH-dependent oxidase of phagocytes. Proc Assoc Am Physicians 1999;111:373-382.
9. Ezekowitz RA. Update on chronic granulomatous disease: the concept of the near-normal host. Curr Clin Top Infect Dis 2000;20:325-334.
10. Levy O. Antibiotic proteins of polymorphonuclear leukocytes. Eur J Haematol 1996;56:263-277.
11. Gabay JE, Heiple JM, Cohn ZA, Nathan CF. Subcellular location and properties of bactericidal factors from human neutrophils. J Exp Med 1986;164:1407-1421.
12. Flemming A. On a remarkable bacteriolytic element found in tissues and secretions. Proc R Soc Lond B Biol Sci 1922;93:306-317.
13. Weiss J, Elsbach P, Olsson I, Odeberg H. Purification and characterization of a potent bactericidal and membrane active protein from the granules of human polymorphonuclear leukocytes. J Biol Chem 1978;253: 2664-2672.
14. Lehrer RI, Selsted ME, Szklarek D, Fleischmann J. Antibacterial Activity of Microbicidal Cationic Proteins 1 and 2, Natural Peptide Antibiotics of Rabbit Lung Macrophages. Infect Immun 1983;42:10-14.
15. Ganz T, Selsted ME, Szklarek D et al. Defensins. Natural Peptide Antibiotics of Human Neutrophils. J Clin Invest 1985;6:1427-1435.
16. Hoffmann JA, Kafatos FC, Janeway CA, Ezekowitz RB. Phylogenetic perspectives in innate immunity. Science 1999;284:1313-1318.
17. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 2002;415:389-395.
18. Zaiou M, Gallo RL. Cathelicidins, essential gene-encoded mammalian antibiotics. J Mol Med 2002;80:549-561.
19. Frohm M, Agerberth B, Ahangari G et al. The expression of the gene coding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders. J Biol Chem 1997;272:15258-15263.
20. Nilsson MF, Sandstedt B, Sorensen O et al. The human cationic antimicrobial protein (hCAP18), a peptide antibiotic, is widely expressed in human squamous epithelia and co-localizes with interleukin 6. Infect Immun 1999;67:2561-2566.
21. Malm J, Sørensen O, Persson T et al. The Human Cationic Antimicrobial Protein (hCAP-18) Is Expressed in the Epithelium of Human Epididymis, Is Present in Seminal Plasma at High Concentrations, and Is Attached to Spermatozoa. Infect Immun 2000;68:4297-4302.
22. Murakami M, Ohtake T, Dorschner RA et al. Cathelicidin anti-microbial Peptide expression in sweat, an innate defense system for the skin. J Invest Dermatol 2002;119:1090-1095.
23. Murakami M, Ohtake T, Dorschner RA, Gallo RL. Cathelicidin antimicrobial peptides are expressed in salivary glands and saliva. J Dent Res 2002;81:845-850.
24. Murakami M, Ohtake T, Dorschner RA et al. Cathelicidin anti-microbial peptide expression in sweat, an innate defense system for the skin. J Invest Dermatol 2002;119:1090-1095.
25. Di Nardo A, Vitiello A, Gallo RL. Cutting Edge: Mast Cell Antimicrobial Activity Is Mediated by Expression of Cathelicidin Antimicrobial Peptide. J Immunol 2003;170:2274-2278.
26. Agerberth B, Charo J, Werr J et al. The human antimicrobial and chemotactic peptides LL-37 and alpha- defensins are expressed by specific lymphocyte and monocyte populations. Blood 2000;96:3086-3093.
27. Ritonja A, Kopitar M, Jerala R, Turk V. Primary structure of a new cysteine proteinase inhibitor from pig leucocytes. FEBS Lett 1989;255: 211-214.
28. Ganz T. Biosynthesis of defensins and other antimicrobial peptides. Antimicrobial peptides. Wiley, Chichester: Ciba Foundation Symposium 186; 1994:62-76.
29. Zanetti M, Litteri L, Griffiths G, Gennaro R, Romeo D. Stimulus-induced maturation of probactenecins, precursors of neutrophil antimicrobial polypeptides. J Immunol 1991;146:4295-4300.
30. Panyutich P, Shi J, Boutz PL, Zhao C, Ganz T. Porcine polymorphonuclear leukocytes generate extracellular microbial activity by elastase-mediated activation of secreted proprotegrins. Infect Immun 1997;65:978-985.
31. Zaiou M, Nizet V, Gallo RL. Antimicrobial and Protease Inhibitory Functions of the Human Cathelicidin (hCAP18/LL-37) Prosequence. J Invest Dermatol 2003;120:810-816.
32. Wilson CL, Ouellette AJ, Satchell DP et al. Regulation of intestinal alpha-defensin activation by the metalloproteinase matrilysin in innate host defense. Science 1999;286:113-117.
33. Cole AM, Shi J, Ceccarelli A et al. Inhibition of neutrophil elastase prevents cathelicidin activation and impairs clearance of bacteria from wounds. Blood 2001;97:297-304.
34. Cowland JB, Johnsen AH, Borregaard N. hCAP-18, a cathelin/pro-bactenecin-like protein of human neutrophil specific granules. FEBS Lett 1995;368:173-176.
35. Larrick JW, Michimasa H, Balint RF et al. Human CAP18: a novel antimicrobial lipopolysaccharide-binding protein. Infect Immun 1995;63: 1291-1297.
36. Agerberth B, Gunne H, Odeberg J et al. FALL-39, a putative human peptide antibiotic, is cysteine-free and expressed in bone marrow and testis. Proc Natl Acad Sci USA 1995;92:195-199.
37. Turner J, Cho Y, Dihn N-N, Waring A, Lehrer RI. Activities of LL-37, a Cathelin-Associated Antimicrobial Peptide of Human Neutrophils. J Antimicrob Chemother 1998;42:2206-2214.
38. Nagaoka I, Hirota S, Niyonsaba F et al. Cathelicidin family of antibacterial peptides CAP18 and CAP11 inhibit the expression of TNF-alpha by blocking the binding of LPS to CD14(+) cells. J Immunol 2001;167: 3329-3338.
39. Koczulla R, Von Degenfeld G, Kupatt C et al. An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. J Clin Invest 2003;111:1665-1672.
40. Yang D, Chen Q, Schmidt AP et al. LL-37, the Neutrophil Granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor -like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophil, monocytes, and T cells. J Exp Med 2000;192:1069-1074.
41. Böyum A. Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Lab Inves. 1968;21:77-90.
42. Sengeløv H, Kjeldsen L, Borregaard N. Control of exocytosis in early neutrophil activation. J Immunol 1993;150:1535-1543.
43. Follin P. Skin chamber technique for study of in vivo exudated human neutrophils. J Immunol Methods 1999;232:55-65.
44. Borregaard N, Sehested M, Nielsen BS, Sengeløv H, Kjeldsen L. Biosynthesis of granule proteins in normal human bone marrow cells. Gelatinase is a marker of terminal neutrophil differentiation. Blood 1995;3: 812-817.
45. Cowland JB, Borregaard N. Isolation of neutrophil precursors from bone marrow for biochemical and transcriptional analysis. J Immunol Methods 1999;232:191-200.
46. Borregaard N, Heiple JM, Simons ER, Clark RA. Subcellular localizations of the b-cytochrome component of the human neutrophil microbial oxidase: Translocation during Activation. J Cell Biol 1983;97:52-61.
47. Kjeldsen L, Sengeløv H, Lollike K, Nielsen MH, Borregaard N. Isolation and characterization of gelatinase granules from human neutrophils. Blood 1994;6:1640-1649.
48. Finley PR, Schifman RB, Williams RJ, Lichti DA. Cholesterol in High-Density lipoprotein: Use of Mg2+/Dextran Sulfate in its enzymic Measurement. Clin Chem 1978;24:931-933.
49. Bronzert TJ, Brewer Jr. HB. New Micromethod for Measuring Cholesterol in Plasma Lipoprotein Fraction. Clin Chem 1977;23:2089-2098.
50. Kjeldsen L, Bjerrum OW, Askaa J, Borregaard N. Subcellular localization and release of human neutrophil gelatinase, confirming the existence of separate gelatinase-containing granules. Biochem J 1992;287:603-610.
51. Kjeldsen L, Bjerrum OW, Hovgaard D et al. Human Neutrophil Gelatinase: A marker for circulating blood neutrophils. Purification and quantitation by enzyme linked immunosorbent assay. Eur J Haematol 1992; 49:180-191.
52. Lollike K, Kjeldsen L, Sengeløv H, Borregaard N. Lysozyme in human neutrophils and plasma. A parameter of myelopoietic activity. Leukemia. 1995;9:159-164.
53. Johansson J, Gudmundsson GH, Rottenberg ME, Berndt KD, Agerberth B. Conformation-dependent Antibacterial Activity of the Naturally Occurring Human Peptide LL-37. J Biol Chem 1998;273:3718-3724.
54. Wang Y, Agerberth B, Löthgren A, Almstedt A, Johansson J. Apolipoprotein A-I Binds and Inhibits the Human Antibacterial/Cytotoxic Peptide LL-37. J Biol Chem 1998;273:33115-33118.
55. Peck-Miller KA, Darveau RP, Fell HP. Identification of serum components that inhibit the tumoricidal activity of amphiphilic alpha helical peptides. Cancer Chemother Pharmacol 1993;32:109-115.
56. Kjeldsen L, Sengeløv H, Borregaard N. Subcellular fractionation of human neutrophils on percoll density gradients. J Immunol Methods 1999; 232:131-143.
57. Borregaard N, Cowland JB. Granules of the human neutrophilic polymorphonuclear leukocyte. Blood 1997;89:3503-3521.
58. Nagaoka I, Hirata M, Sugimoto K et al. Evaluation of the expression of human CAP18 gene during neutrophil maturation in the bone marrow. J Leukoc Biol 1998;64:845-852.
59. Cowland JB, Borregaard N. The individual regulation of granule protein mRNA levels during neutrophil maturation explains the heterogeneity of neutrophil granules. J Leuk Biol 1999;66:989-995.
60. Zanetti M, Litteri L, Gennaro R, Horstmann H, Romeo D. Bactenecins, defense polypeptides of bovine neutrophils, are generated from precursor molecules stored in large granules. J Cell Biol 1990;111:1363-1371.
61. Baggiolini M, Horisberger U, Gennaro R, Dewald B. Identification of three types of granules in neutrophils of ruminants. Laboratory Investigation 1985;52:151-158.
62. Gennaro R, Dewald B, Horisberger U, Gubler HU, Baggiolini M. A novel type of cytoplasmic granule in bovine neutrophils. J Cell Biol 1983;96: 1651-1661.
63. Nagaoka I, Tsutsumi-Ishii Y, Yomogida S, Yamashita T. Isolation of cDNA encoding guinea pig neutrophil cationic antibacterial polypeptide of 11 kDa (CAP11) and evaluation of CAP11 mRNA expression during neutrophil maturation. J Biol Chem 1997;272:22742-22750.
64. Yount NY, Yuan J, Tarver A et al. Cloning and expression of bovine neutrophil beta-defensins. Biosynthetic profile during neutrophilic maturation and localization of mature peptide to novel cytoplasmic dense granules. J Biol Chem 1999;274:26249-26258.
65. Sengeløv H, Follin P, Kjeldsen L et al. Mobilization of granules and secretory vesicles during in vivo exudation of human neutrophils. J Immunol 1995;154:4157-4165.
66. Scocchi M, Skerlavaj B, Romeo D, Gennaro R. Proteolytic cleavage by neutrophil elastase converts inactive storage proforms to antibacterial bactenecins. Eur J Biochem 1992;209:589-595.
67. Barrett AJ. Leukocyte elastase. Methods Enzymol 1981;80:581-588.
68. Gudmundsson GH, Agerberth B, Odeberg J et al. The human gene FALL39 and processing of the cathelin precursor to the antibacterial peptide LL-37 in granulocytes. Eur J Biochem 1996;238:325-332.
69. Baici A, Szedlacsek SE, Fruh H, Michel BA. pH-dependent hysteretic behaviour of human myeloblastin (leucocyte proteinase 3). Biochem J 1996;317 (Pt 3):901-905.
70. Scocchi M, Wang S, Zanetti M. Structural organization of the bovine cathelicidin gene family and identification of a novel member. FEBS Lett 1997;417:311-315.
71. Zhao C, Ganz T, Lehrer RI. The structure of protegrin genes. FEBS Lett 1995;368:197-202.
72. Zhao C, Ganz T, Lehrer RI. Structures of genes for two cathelin-associated antimicrobial peptides: prophenin-2 and PR-39. FEBS Lett 1995; 376:130-134.
73. Gudmundsson GH, Magnusson KP, Chowdhary BP et al. Stucture of the gene for porcine peptide antibiotic PR-39, a cathelin gene family member: Comparative mapping of the locus for the human peptide antibiotic Fall-39. Proc Natl Acad Sci USA 1995;92:7085-7089.
74. Larrick JW, Lee J, Ma S et al. Structural, functional analysis and localization of the human CAP18 gene. FEBS Lett 1996;398:74-80.
75. Ghosh D, Porter E, Shen B et al. Paneth cell trypsin is the processing enzyme for human defensin-5. Nat Immunol 2002;3:583-590.
76. Bals R, Wang X, Zasloff M, Wilson JM. The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of human lung where it has broad antimicrobial activity at the airway surface. Proc Natl Acad Sci USA 1998;95:9541-9546.
77. Reid WA, Vongsorasak L, Svasti J, Valler MJ, Kay J. Identification of the acid proteinase in human seminal fluid as a gastricsin originating in the prostate. Cell Tissue Res 1984;236:597-600.
78. Szecsi PB, Lilja H. Gastricsin-mediated proteolytic degradation of human seminal fluid proteins at pH levels found in the human vagina. J Androl 1993;14:351-358.
79. Szecsi PB, Dalgaard D, Stakemann G, Wagner G, Foltmann B. The concentration of pepsinogen C in human semen and the physiological activation of zymogen in the vagina. Biol Reprod 1989;40:653-659.
80. Dorschner RA, Pestonjamasp VK, Tamakuwala S et al. Cutaneous injury induces the release of cathelicidin anti-microbial peptides active against group A Streptococcus. J Invest Dermatol 2001;117:91-97.
81. Harder J, Bartels J, Christophers E, Schröder J-M. A peptide antibiotic from human skin. Nature 1997;387:861.
82. Harder J, Bartels J, Christophers E, Schroder JM. Isolation and Characterization of Human beta-Defensin-3, a Novel Human Inducible Peptide Antibiotic. J Biol Chem 2001;276:5707-5713.
83. O'Neil DA, Porter EM, Elewaut D et al. Expression and regulation of the human beta-defensins hBD-1 and hBD-2 in intestinal epithelium. J Immunol 1999;163:6718-6724.
84. Sallenave JM, Shulmann J, Crossley J, Jordana M, Gauldie J. Regulation of secretory leukocyte proteinase inhibitor (SLPI) and elastase-specific inhibitor (ESI/elafin) in human airway epithelial cells by cytokines and neutrophilic enzymes. Am J Respir Cell Mol Biol 1994;11:733-741.
85. Cowland JB, Sørensen OE, Sehested M, Borregaard N. Neutrophil Gelatinase-associtated lipocalin (NGAL) is upregulated in human epithelial cells by IL-1β but not by TNF-α. 2003. Submitted for publication.
86. Goetz DH, Holmes MA, Borregaard N et al. The Neutrophil Lipocalin NGAL Is a Bacteriostatic Agent that Interferes with Siderophore-Mediated Iron Acquisition. Mol Cell 2002;10:1033-1043.
87. Hiemstra PS, Maassen RJ, Stolk J et al. Antibacterial activity of antileukoprotease. Infect Immun 1996;64:4520-4524.
88. Singer AJ, Clark RA. Cutaneous wound healing. N Engl J Med 1999;341: 738-746.
89. Krane JF, Murphy DP, Carter DM, Krueger JG. Synergistic effects of epidermal growth factor (EGF) and insulin-like growth factor I/somatomedin C (IGF-I) on keratinocyte proliferation may be mediated by IGF-I transmodulation of the EGF receptor. J Invest Dermatol 1991;96:419-424.
90. Kumar V, Bustin SA, McKay IA. Transforming growth factor alpha. Cell Biol Int 1995;19:373-388.
91. Calafat J, Janssen H, Ståhle-Bäckdahl M et al. Human Monocytes and Neutrophils store Transforming Growth Factor-a in a Subpopulation of Cytoplasmatic Granules. Blood 1997;90:1255-1266.
92. Egesten A, Calafat J, Knol EF, Janssen H, Walz TM. Subcellular localization of transforming growth factor-alpha in human eosinophil granulocytes. Blood 1996;87:3910-3918.
93. Nizet V, Ohtake T, Lauth X et al. Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature 2001;414:454-457.
94. Cole AM, Liao HI, Stuchlik O et al. Cationic polypeptides are required for antibacterial activity of human airway fluid. J Immunol 2002;169: 6985-6991.